论文部分内容阅读
目的:探讨小牛血清去蛋白注射液在急性脑梗死(ACI)患者中的临床疗效。方法:94例ACI患者以随机数字表法分为两组,其中观察组46例,对照组48例。治疗方法:对照组:传统治疗;观察组:在传统治疗基础上加用小牛血清去蛋白注射液治疗。对比两组患者临床疗效。结果:观察组基本治愈率及总有效率分别为56.5%和93.5%,均显著高于对照组的33.3%和70.8%;两组患者经上述治疗后,MESSS评分均显著降低,且治疗后观察组显著低于对照组;两组患者经过上述治疗后,上下肢FMA评分均显著增高,且治疗后观察组显著高于对照组;两组治疗后ADL评分均显著增高,且治疗后观察组显著高于对照组。结论:小牛血清去蛋白注射液用于ACI患者的治疗,可有效减轻患者神经功能缺损,使患者获得更好、更快的神经功能恢复,提高日常生活能力,安全有效,值得推广。
Objective: To investigate the clinical efficacy of deproteinization of bovine serum in patients with acute cerebral infarction (ACI). Methods: Ninety-four patients with ACI were divided into two groups according to random number table, including 46 cases in observation group and 48 cases in control group. Treatment: control group: conventional treatment; observation group: based on the traditional treatment plus bovine serum protein injections. The clinical efficacy of two groups were compared. Results: The basic cure rate and total effective rate in the observation group were 56.5% and 93.5%, respectively, which were significantly higher than those in the control group (33.3% and 70.8%). After treatment, MESSS score decreased significantly in both groups, and after treatment Group was significantly lower than the control group; after the above two groups of patients after treatment, upper and lower extremity FMA scores were significantly increased, and the observation group was significantly higher than the control group after treatment; ADL score was significantly increased after treatment in both groups and the treatment group was significantly Higher than the control group. Conclusion: The deproteinization of bovine serum for the treatment of patients with ACI can effectively reduce the neurological deficit in patients with better and faster recovery of neurological function, improve the ability of daily living, safe and effective, and worth promoting.